APA aipamena

Dou, D., Ge, X., Wang, X., Xu, X., Zhang, Z., Seng, J., . . . Han, M. (2019). EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression. Onco Targets Ther.

Chicago Style aipamena

Dou, Dongwei, Xin Ge, Xinxing Wang, Xiaodong Xu, Zhe Zhang, Jingjing Seng, Zhang Cao, Yuanting Gu, and Mingli Han. "EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing MiR-381 Expression." Onco Targets Ther 2019.

MLA aipamena

Dou, Dongwei, et al. "EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing MiR-381 Expression." Onco Targets Ther 2019.